We’re re-imaging how mental health is managed and measured, while delivering better outcomes.
We’re using technology to help our members access care whenever and wherever they need it. Our clinical staff delivers cognitive-based therapy and medication management through our smartphone app. We’ve developed and patented a set of digital markers that measure brain function through passive interaction patterns captured through a person’s smartphone, and these findings correlate with traditional neurocognitive assessments. We’re using these insights to proactively help our members manage their mental health, stay healthier, and get care when we think they might need it.
We’re serving people living with a serious mental illness (SMI), like schizophrenia, bipolar disorder, or major depressive disorder. 1 of 22 people in the US live with an SMI—that’s 11.4 million people.
Our growing team of 80+ employees is made up of brilliant people who’ve led institutions like the National Institute for Mental Health, Stanford Center for Neurobiological Imaging, and the National Cancer Institute. We’ve led consumer technology companies at places like Uber, Facebook, Apple and Google. And we’re clinical and healthcare professionals from acclaimed organizations like Stanford Health Care, Oscar Health, Verily, and CMS.
We’re based in Mountain View and our clinical staff live in the markets where our members live. We’re opening an office in San Francisco in Q1 2020. Backed by industry leading investors like General Catalyst, Bezos Expeditions, and Foresite Capital, we’re in our Series B and have raised $60M in funding.